Jade Biosciences (JBIO) Operating Leases (2021 - 2026)
Jade Biosciences (JBIO) posted Operating Leases of $679000.0 for Q1 2026, down 6.22% on a QoQ basis from $724000.0 in Q4 2025.
Jade Biosciences (JBIO) Operating Leases (2021 - 2026) Analysis & Trends
Jade Biosciences' Operating Leases history runs 6 years deep, the most recent figure standing at $679000.0 for Q1 2026.
- Quarterly Operating Leases changed N/A year-over-year to $679000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $679000.0 (changed N/A YoY) and the FY2025 annual result came in at $724000.0, changed N/A from the prior year.
- Operating Leases was $679000.0 for Q1 2026 at Jade Biosciences, down from $724000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.2 million in Q2 2022 and bottomed at $81000.0 in Q3 2024.
- A 5-year average of $562200.0 and a median of $591000.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases sank 77.37% — and 2025, when it jumped 764.2%.
- Jade Biosciences' Operating Leases stood at $705000.0 in 2022, then sank by 63.83% to $255000.0 in 2023, then slumped by 68.24% to $81000.0 in 2024, then surged by 793.83% to $724000.0 in 2025, then retreated by 6.22% to $679000.0 in 2026.
- Business Quant data shows JBIO's Operating Leases at $679000.0 in Q1 2026, $724000.0 in Q4 2025, and $700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 679,000.00 |
| Dec 31, 2025 | 724,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 792,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 206,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 255,000.00 |
| Sep 30, 2023 | 358,000.00 |
| Jun 30, 2023 | 476,000.00 |
| Mar 31, 2023 | 591,000.00 |
| Dec 31, 2022 | 705,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 528,000.00 |
| Dec 31, 2021 | 382,000.00 |
| Sep 30, 2021 | 599,000.00 |